close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Biotech and Pharmaceuticals

Recent news which mentions Biotech and Pharmaceuticals

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
32 33 Next >
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
Tags US: News LILLY DRN Companies
From CNBC.com News
Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals
Tags Health & Science Bristol/Myers Squibb Co UnitedHealth Group Inc
From CNBC.com News
Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand
Tags Earnings Health care industry Health & Science
From CNBC.com News
Eli Lilly CEO expects new weight loss pill to be approved next year
Tags Business Health care industry Health & Science
From CNBC.com News
Moderna stock plunges 18% after company lowers 2025 sales forecast by $1 billion
Tags Biotechnology Moderna Inc Health & Science
From CNBC.com News
Walgreens results top estimates as drugstore chain works to slash costs
Tags Business Pharmaceuticals Health care industry
From CNBC.com News
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says
Tags Health & Science Novo Nordisk A/S Social issues
From CNBC.com News
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
Tags Health care industry Accolade Inc Madrigal Pharmaceuticals Inc
From CNBC.com News
J&J says its lung cancer drug combination keeps people alive longer
Tags Health & Science Health care industry Biotech and Pharmaceuticals
From CNBC.com News
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
Tags Health care policy Biotechnology Health & Science
From CNBC.com News
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
Tags Biotechnology Health & Science Novo Nordisk A/S
From CNBC.com News
Novo Nordisk shares plunge 22% after CagriSema obesity drug trial results
Tags Biotechnology Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortage
Tags Social issues Health & Science Biotechnology
From CNBC.com News
Why Americans are outraged over health insurance — and what could change
Tags UnitedHealth Group Inc Health & Science Biotechnology
From CNBC.com News
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Tags Pfizer Inc AstraZeneca PLC Roche Holding AG
From CNBC.com News
Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition
Tags Science Healthy Returns Biotech and Pharmaceuticals
From CNBC.com News
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.